loading

Unicycive Therapeutics Inc Stock (UNCY) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - 0.675
Operating Expenses
45.79%
9.204
6.313 5.938 4.322 4.877
Interest Income/Expense
5.26%
0.02
0.019 0.018 0.032 0.012
Operating Income/Loss
45.79%
-9.204
-6.313 -5.938 -4.322 -4.202
Income/Loss From Continuing Operations Before Tax
-20.96
- -4.333 -3.838 -14.57
Income/Loss From Continuing Operations After Tax
168.83%
-20.96
-7.798 -4.333 -3.838 -14.57
Net Income/Loss
168.83%
-20.96
-7.798 -4.333 -3.838 -14.57
Preferred Stock Dividends And Other Adjustments
0.208
- 0.072 0.603 0.192
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
915.17%
34.91
3.4391 32.63 15.23 15.23
Diluted Average Shares
915.17%
34.91
3.4391 32.63 15.23 15.23
Basic Earnings Per Share
281.25%
-0.61
-0.16 -0.13 -0.29 -0.97
Diluted Earnings Per Share
281.25%
-0.61
-0.16 -0.13 -0.29 -0.97
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.208
- 0.072 - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):